The efficacy and safety of genetically engineered allogeneic human chondrocytes expressing TGF-β1 in patients with grade 3 chronic degenerative joint disease of the knee. (April 2018)

Record Type:: Journal Article
Title:: The efficacy and safety of genetically engineered allogeneic human chondrocytes expressing TGF-β1 in patients with grade 3 chronic degenerative joint disease of the knee. (April 2018)
Main Title:: The efficacy and safety of genetically engineered allogeneic human chondrocytes expressing TGF-β1 in patients with grade 3 chronic degenerative joint disease of the knee
Authors:: Kalsi, G.
Parvizi, J.
Bramlet, D.
Romness, D.
Guermazi, A.
Noh, M.
Khlopas, A.
Mont, M.A.
Abstract:
Is Part Of:: Osteoarthritis and cartilage. Volume 26(2018)Supplement 1
Journal:: Osteoarthritis and cartilage
Issue:: Volume 26(2018)Supplement 1
Issue Display:: Volume 26, Issue 1 (2018)
Year:: 2018
Volume:: 26
Issue:: 1
Issue Sort Value:: 2018-0026-0001-0000
Page Start:: S300
Page End:
Publication Date:: 2018-04
Subjects:: Osteoarthritis -- Periodicals
Cartilage -- Periodicals
Osteoarthritis -- Periodicals
Cartilage -- Periodicals
Arthrose -- Périodiques
Articulations -- Maladies -- Périodiques
616.7223005
Journal URLs:: http://www.sciencedirect.com/science/journal/10634584 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/10634584 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.joca.2018.02.603 ↗
Languages:: English
ISSNs:: 1063-4584
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 6303.858870
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 6332.xml